Use of 1,3-diphenylprop-2-en-1-one derivatives for treating liver disorders
AssigneeGenfit
InventorsRaphaël Darteil, Rémy Hanf, Dean Hum
Life of this patent
Estimating the term…
Abstract
The invention provides 1,3-diphenylprop-2-en-1-one derivatives and pharmaceutical compositions comprising the same for treating liver disorders, in particular those requiring the reduction of plasma level of biochemical markers such as amino-transferases. The 1,3-diphenylprop-2-en-1-one derivatives of General Formula (I) have hepatoprotective properties and can be used in methods for treating liver disorders involving the pathological disruption, inflammation, degeneration, and/or proliferation of liver cells, such as liver fibrosis or fatty liver disease.
Claims12
A method for the treatment of a liver disorder, comprising administering to a subject in need thereof a compound of General Formula (I)
- in which:
- X1 represents a halogen, a R1, or G1-R1 group;
- A represents a CH═CH or a CH2-CH2 group;
- X2 represents a G2-R2 group;
- G1 and G2, identical or different, represent an atom of oxygen or sulfur;
- R1 represents a hydrogen atom, an unsubstituted alkyl group, an aryl group or an alkyl group that is substituted by one or more halogen atoms, an alkoxy or an alkylthio group, cycloalkyl groups, cycloalkylthio groups or heterocyclic groups;
- R2 represents an alkyl group substituted by at least a —COOR3 group, wherein R3 represents a hydrogen atom, or an alkyl group that is substituted or not by one or more halogen atoms, cycloalkyl groups, or heterocyclic groups;
- R4 and R5, identical or different, representing an alkyl group that is substituted or not by one or more halogen atoms, cycloalkyl groups, heterocyclic groups.
Dependencies are inferred from the claim text.